Four New Grants for Early Detection Research

Four research teams from the NKI Center for Early Diagnostics have been awarded funding for new projects to improve the early detection of cancer. These initiatives are made possible by financial support from KWF Dutch Cancer Society and donations from the DNA Gala. The studies are expected to boost efforts in early cancer detection significantly.

New Research Projects

The following projects can get started:

Smart biopsy needle
The research group led by surgeon Theo Ruers is working on the development of a “smart” biopsy needle. This advanced needle incorporates complex technology that can immediately determine whether there are malignant cells present in the tissue after sampling. This would provide patients with instant results, reducing anxiety and minimizing the need for additional biopsies.

Hyperspectral imaging
Senior researcher Behdad Dasht Bozorg is working on an innovative device for the early diagnostics of skin cancer. This device combines artificial intelligence with hyperspectral imaging. The specialized technique enables the detection of skin cancer without the need for unnecessary tissue sampling. The tool is expected to become suitable for home use via mobile phones.

Risk model with point-of-care ultrasound
Urologist Pim van Leeuwen is leading a study to improve risk assessment for prostate cancer using a Point-of-Care Ultrasound device. This specialized ultrasound tool provides imaging of the prostate, while collecting valuable information to assess prostate cancer risk. The goal is to implement this risk assessment method in general practice.

Early detection of colorectal cancer: FIT implementation study
Gastroenterologist Monique van Leerdam is heading the FIT implementation study. In the Netherlands, the fecal immunochemical test (FIT) is used in colorectal cancer screening, with a high cut-off threshold. England uses FIT with a lower cut-off threshold as a triage tool in general practice as well. This study will evaluate the use of FIT with a lower cut-off threshold in general practice and assess its outcomes.

The impact of early detection

The NKI Center for Early Diagnostics aims to facilitate and promote the development and implementation of new tests and methods in early diagnostics. In addition, the center focuses on better identifying individuals at higher risk for cancer, allowing for more efficient testing strategies. By advancing research into innovative diagnostic tests and targeting high-risk groups, the Center aims to make a significant impact in cancer detection.

Prostate cancer is now the most common cancer type among men

Prostate cancer is now the most common form of cancer among men. Recent figures from the IKNL show that the disease is diagnosed almost as often as breast cancer, with over 15,000 new cases in the Netherlands in 2024. The number of men with prostate cancer is expected to increase further in the coming decades, mainly due to the aging population.

Four New Grants for Early Detection Research

Four research teams from the NKI Center for Early Diagnostics have been awarded funding for new projects to improve the early detection of cancer. These initiatives are made possible by financial support from the Dutch Cancer Society (KWF Kankerbestrijding) and donations from the DNA Benefit Gala. The studies are expected to significantly boost efforts in early cancer detection.

Breast Cancer Awareness at Stichting Gouden Handen

Our healthcare providers were recently invited again to visit Stichting de Gouden Handen in the Southeastern part of Amsterdam, this time to provide information about breast cancer. Cancer is a difficult topic within certain communities. Stichting Gouden Handen wants to raise awareness about cancer and encourages conversations about cancer among people from various cultural backgrounds. An initiative we wholeheartedly support.

Information on Dense Breast Tissue and the Use of MRI

Over the last weeks, there has been extensive coverage regarding the lack of MRI use for women with dense breast tissue. Women with very dense breast tissue have a proven higher risk of developing breast cancer. Additionally, it is challenging to detect breast cancer in this group using the current screening mammogram available through the national breast cancer screening program. At this time, women in this group are not eligible for reimbursement for an additional MRI in the Netherlands.

New: Center for Early Cancer Diagnostics Expanded to Include Breast Cancer Screening

This week marked the official opening of the new breast cancer diagnostic department at the NKI Center for Early Cancer Diagnostics (CVV). This expansion is an important milestone for the Center’s mission: to promote new advancements in early cancer detection and implement them in practice as quickly as possible. The official opening was conducted by screening patient and artist Aysha de Groot, also known as "Meis." She shared her powerful personal story with attendees and performed her self-written song "Rond," in which she conveyed her personal battle with cancer.

Donors personally received at the NKI Center for Early Diagnostics

We recently organized a festive event and tour at the NKI Center for Early Diagnostics for donors of the AVL Foundation. This group of generous benefactors has specifically donated to the theme of early cancer detection, including during a special benefit gala focused on this theme.

Improved Prostate Cancer Diagnostics

The European Association of Urology has recently hosted the largest urological conference in Europe. During the event, Marias Hagens, former physician-researcher in the Urology Department at the Netherlands Cancer Institute, presented research data regarding the improvement of the diagnostic process for prostate cancer from the Center for Early Diagnostics. This research provided new insights into ways to improve prostate cancer diagnostics.

The NKI starts offering prostate consultations at SALT in Zaandam

The NKI Center for Early Diagnostics has initiated a collaboration with diagnostic center SALT to improve early detection of prostate cancer. Last week the NKI started offering prostate consultations at SALT in Zaandam. The goal of the collaboration is scientific research into a new, risk-weighted care pathway to better detect aggressive tumors and decrease diagnoses and treatment for low-grade prostate cancer. The study is financed by KWF Dutch Cancer Society.

NKI signs Zonvenant

Skin cancer is the most common cancer type in the Netherlands. One in five people will develop skin cancer, and we expect that the number of diagnoses will only increase. At the Netherlands Cancer Institute, we know what kind of damage the sun can cause, which is why we joined the Zonvenant as a strategic partner: an initiative of the Huidfonds, the Dutch skin foundation. Through this declaration of intent, we will work harder to inform the public, patients, and colleagues of the risks of developing skin cancer through sun exposure.

New Research Projects

The impact of early detection

News